Proteomics Intl Labs Ltd has released a press release.
CE Mark for predictive test for diabetic kidney disease
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Appendix 4C - September 2019 Quarterly Report
- PromarkerD IVD successfully developed and validated
- PromarkerD diabetic kidney disease test launched in Spain
- PromarkerD test ready for launch in Europe
- Appendix 4C - June 2019 Quarterly Report
Later from Proteomics International Laboratories
- Proteomics raises $3m in heavily oversubscribed Placement
- Partnership provides funding for cutting-edge facility
- CE Mark for PromarkerD Hub predictive software for DKD
- Appendix 4C - December 2019 Quarterly Report
- Proteomics patents biomarkers for diagnosis of endometriosis
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories